Shuttle Pharmaceuticals (SHPH) Competitors $3.72 -0.10 (-2.62%) Closing price 07/30/2025 04:00 PM EasternExtended Trading$3.83 +0.11 (+2.93%) As of 07/30/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. APLM, GTBP, INAB, MYNZ, HCWB, ADIL, JBIO, NKGN, LIAN, and PRTGShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Apollomics (APLM), GT Biopharma (GTBP), IN8bio (INAB), Mainz Biomed (MYNZ), HCW Biologics (HCWB), Adial Pharmaceuticals (ADIL), Jade Biosciences (JBIO), NKGen Biotech (NKGN), LianBio (LIAN), and Portage Biotech (PRTG). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors Apollomics GT Biopharma IN8bio Mainz Biomed HCW Biologics Adial Pharmaceuticals Jade Biosciences NKGen Biotech LianBio Portage Biotech Apollomics (NASDAQ:APLM) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends. Does the media refer more to APLM or SHPH? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for Shuttle Pharmaceuticals and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.89 beat Shuttle Pharmaceuticals' score of 1.87 indicating that Apollomics is being referred to more favorably in the media. Company Overall Sentiment Apollomics Very Positive Shuttle Pharmaceuticals Very Positive Which has more risk and volatility, APLM or SHPH? Apollomics has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.09, meaning that its share price is 209% less volatile than the S&P 500. Which has preferable earnings and valuation, APLM or SHPH? Shuttle Pharmaceuticals has lower revenue, but higher earnings than Apollomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomics$1.49M4.33-$53.86MN/AN/AShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.90 Is APLM or SHPH more profitable? Apollomics' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Shuttle Pharmaceuticals N/A -1,203.10%-370.42% Do insiders and institutionals hold more shares of APLM or SHPH? 19.1% of Apollomics shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryApollomics beats Shuttle Pharmaceuticals on 6 of the 9 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68M$2.51B$5.63B$9.53BDividend YieldN/A1.78%4.71%4.04%P/E Ratio-0.909.4930.2020.54Price / SalesN/A692.12455.8798.78Price / CashN/A159.7936.0158.40Price / Book0.864.968.355.74Net Income-$9.15M$31.62M$3.25B$259.12M7 Day Performance-2.87%-3.12%-2.15%-2.68%1 Month Performance-1.33%9.83%7.97%8.53%1 Year PerformanceN/A-5.59%36.49%14.91% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.876 of 5 stars$3.72-2.6%N/AN/A$1.68MN/A-0.905News CoveragePositive NewsAPLMApollomics1.029 of 5 stars$6.08-4.6%N/A-71.1%$6.68M$1.49M0.0045Positive NewsGap UpHigh Trading VolumeGTBPGT Biopharma1.7116 of 5 stars$2.04-2.9%$11.00+439.2%-23.1%$6.67MN/A-0.368INABIN8bio3.6412 of 5 stars$2.20-6.4%$180.00+8,081.8%-91.4%$6.67MN/A-0.1620Positive NewsMYNZMainz Biomed2.6722 of 5 stars$1.86-5.1%$14.00+652.7%-86.6%$6.40M$890K-0.0330Positive NewsHCWBHCW Biologics2.5417 of 5 stars$4.41+6.3%$35.00+693.7%-82.7%$6.35M$2.57M-0.1940Positive NewsGap UpADILAdial Pharmaceuticals2.6938 of 5 stars$0.61-3.8%$8.00+1,219.9%-52.6%$6.33MN/A-0.4220Gap UpHigh Trading VolumeJBIOJade Biosciences1.9199 of 5 stars$7.53-2.8%$15.00+99.2%N/A$6.33MN/A-0.1320Positive NewsNKGNNKGen Biotech0.2762 of 5 stars$0.14-26.3%N/A-86.9%$6.29MN/A-0.03N/AGap DownLIANLianBioN/A$0.06+18.3%N/A-82.8%$6.16MN/A-0.07110Gap UpPRTGPortage Biotech0.3205 of 5 stars$5.70-4.4%N/A+61.0%$5.98MN/A-0.146 Related Companies and Tools Related Companies APLM Alternatives GTBP Alternatives INAB Alternatives MYNZ Alternatives HCWB Alternatives ADIL Alternatives JBIO Alternatives NKGN Alternatives LIAN Alternatives PRTG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 7/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
